Post Tagged with: "GW Pharma"

GW Pharmaceuticals Up on Encouraging Schizophrenia Data

GW Pharmaceuticals Up on Encouraging Schizophrenia Data

GW Pharmaceuticals plc GWPH was up 7.6% after the company announced encouraging top-line data from an exploratory phase IIa study on cannabidiol in patients suffering from schizophrenia who had previously failed to respond adequately to first-line anti-psychotic medications. In the multi-center, double-blind, placebo-controlled, six-week, phase II study, patients remained on their anti-psychotic medication and were randomized to receive either cannabidiol […]

September 18, 2015 · 0 comments · Investing
Marijuana Investments Bud As Legalization Advances

Marijuana Investments Bud As Legalization Advances

Increasingly conciliatory attitudes toward cannabis regulation in the U.S. are attracting a new wave of investors to the budding legal marijuana field. Now legalized for medical use in 23 states, and for recreational use in four states — Oregon, Colorado, Washington and Alaska — and the District of Columbia, cannabis is seen by some investors as a possibly lucrative, though […]

June 22, 2015 · 0 comments · Investing
GW Pharmaceuticals Raising Cash As Pipeline Of Cannabis-Based Drugs Grows

GW Pharmaceuticals Raising Cash As Pipeline Of Cannabis-Based Drugs Grows

GW Pharmaceuticals (NASDAQ: GWPH) is planning to issue 1.25 million American Depositary shares in a public offering in an effort to raise some fresh cash. The company hasn’t provided many details about the offering, but investors are speculating that the firm is looking to continue expanding its research and development regarding new cannabis-based drugs. Closer To Creating A New Drug […]

May 1, 2015 · 0 comments · Investing
Legal Expert’s Opinion In Buying Marijuana Stocks Right Now

Legal Expert’s Opinion In Buying Marijuana Stocks Right Now

That would be a nightmare scenario for GW Pharma, and its handful of midsized peers, working on marijuana-based medicinal products. What’s next? Summing up, this is a pivotal time in the movement to legalize marijuana. The CARERS Act, or similar legislation, could drive a major shift in the types of companies operating in this field. As a result, the current […]

April 13, 2015 · 0 comments · Investing
Marijuana May Be The Ultimate Treatment, But Research And Development Still Limited

Marijuana May Be The Ultimate Treatment, But Research And Development Still Limited

So far, GW Pharma has had promising results from two drugs currently in clinical trials to help treat cancerous brain tumors and has seen a marked improvement in sufferers of two types of childhood epilepsy using the company’s drug Epidiolex. Effect On Alzheimer’s While few studies have been done regarding the effect of THC on Alzheimer’s, the Journal of Alzheimer’s […]

March 3, 2015 · 0 comments · Investing
Penny Stocks Did This To Marijuana Stocks

Penny Stocks Did This To Marijuana Stocks

Unlike GW Pharma or Insys, which are both legitimate companies trading on the NASDAQ with market caps above $1 billion, most companies selling marijuana (as opposed to marijuana-derived drugs like GW Pharma and Insys) trade over the counter. Not trading on one of the major exchanges introduces all kinds of problems for investors — like low volumes that make it […]

February 27, 2015 · 0 comments · Investing
Marijuana Stocks That Might Not “Light Up” After All

Marijuana Stocks That Might Not “Light Up” After All

Unlike GW Pharma or Insys, which are both legitimate companies trading on the NASDAQ with market caps above $1 billion, most companies selling marijuana (as opposed to marijuana-derived drugs like GW Pharma and Insys) trade over the counter. Not trading on one of the major exchanges introduces all kinds of problems for investors — like low volumes that make it […]

February 22, 2015 · 0 comments · Investing
Diseases That Can Be Cured By Marijuana That You Are Not Aware Of

Diseases That Can Be Cured By Marijuana That You Are Not Aware Of

In 2012, a study published in Translational Psychiatry hinted that cannabinoid CBD may prove to be an attractive substitute for current antipsychotic treatments. In total, the study examined 39 patients, dosing 20 with CBD and 19 with amisulpride. While both led to similar Brief Psychiatric Rating Scale scores upon study completion, it was noted that the CBD group had fewer […]

February 10, 2015 · 0 comments · Investing
What You Need To Know Regarding Medical Pot This Year

What You Need To Know Regarding Medical Pot This Year

It’s also been studying CBD for use in epilepsy. In 2015, GW Pharma is going to roll out more data that investors will be able to dissect and digest, to see whether or not they want to be long the stock heading into the 2016 election year cycle. Personally, I’m not a huge fan of GW Pharma for 2015 because […]

January 25, 2015 · 0 comments · Investing
A Much Smarter Investment Than Marijuana Stocks

A Much Smarter Investment Than Marijuana Stocks

Both companies are still largely clinical-stage in their development, and weak trial results or an FDA thumbs-down on any of their cannabinoid-based drugs could be devastating their stock price. This makes both GW Pharma and Insys risky, but relatively transparent, investments. On the other hand, there are no shortage of penny stocks geared at tugging on the heart strings of […]

January 22, 2015 · 0 comments · Investing